Medicines, Poisons and Therapeutic Goods Act 2022
73Suspension or revocation of approval
Start here
Get a plain-English read of 73
Turn the raw legal text into a practical explanation grounded in Medicines, Poisons and Therapeutic Goods Act 2022.
73 Suspension or revocation of approval
73 Suspension or revocation of approval
(1) The Health Secretary may, subject to the regulations, suspend or revoke an approval for reasons the Health Secretary considers appropriate.
(2) The regulations may provide for the circumstances in which an approval, or kind of approval, may or must be suspended or revoked.
(3) An approval granted to a class of persons may be suspended or revoked in its application to—
(a) all the persons of the class, or
(b) specified persons of the class.
(4) Notice of the suspension or revocation of an approval must—
(a) be written, and
(b) specify the following—
(i) the date or time from which the suspension or revocation takes effect,
(ii) the grounds for the suspension or revocation,
(iii) for a suspension—the period of suspension.
(5) Notice of the suspension or revocation of an approval granted to a particular person must be given to the person.
(6) Notice of the suspension or revocation of an approval granted to a class of persons must be—
(a) if the suspension or revocation applies to all the persons of the class—published on the Ministry of Health’s website, or
(b) if the suspension or revocation applies to a specified person of the class—given to the person.